Taiwan’s NaviFUS Corporation (浩宇生醫, 6872.TWO) is set to go public on March 7, making waves in the focused ultrasound therapy sector! 
Why It Matters?

• One of the few companies globally developing focused ultrasound therapy & contrast agents
• Taiwan’s ultrasound industry has traditionally focused on probes, making this a game-changer 
• A rising player in innovative medical devices, boosting Taiwan’s global competitiveness

Who else is in the game?
This article covers key players, market trends, and strategic moves in Taiwan’s ultrasound medical sector! Don’t miss out! 
Read More: https://reurl.cc/V0ryRA
#GBIIndustryNews # NaviFUS #UltrasoundTech #MedicalInnovation #TaiwanBiotech #FocusedUltrasound #HealthcareTech #EpiSonica #MaximaBiotech #TRUST_BIO-SONICS